HOUSE OF REPRESENTATIVES

THE THIRTIETH LEGISLATURE

REGULAR SESSION OF 2020

 

COMMITTEE ON HEALTH

Rep. John M. Mizuno, Chair

Rep. Bertrand Kobayashi, Vice Chair

 

Rep. Della Au Belatti

Rep. Calvin K.Y. Say

Rep. Nadine K. Nakamura

Rep. James Kunane Tokioka

Rep. Joy A. San Buenaventura

Rep. Gene Ward

 

NOTICE OF HEARING

 

DATE:

Tuesday, February 4, 2020

TIME:

8:30 a.m.

PLACE:

Conference Room 329

State Capitol

415 South Beretania Street

 

A G E N D A

 

 

HB 2561

Status

RELATING TO PRESCRIPTION DRUG RATE SETTING.

Establishes a prescription affordability commission within the Department of Commerce and Consumer Affairs to review prescription drug costs and establish levels of reimbursement. Appropriates moneys.

 

HLT, CPC, FIN

HB 2108

Status

RELATING TO HEALTH CARE.

Requires the Hawaii Health Authority to establish a five-year all-payer health care pilot program in a county with a population greater than 500,000. Requires certain payers to deposit contributions into the all-payer health care pilot program revolving fund, to be distributed to provider hospitals participating in the pilot program. Specifies budgetary requirements and calculation of fees for the pilot program. Requires reports to the legislature. Appropriates funds.

 

HLT, CPC, FIN

HB 2504

Status

RELATING TO HEALTH INSURANCE.

Establishes disclosure and consent requirements for nonparticipating health care providers. Prohibits nonparticipating health care providers from balance billing patients in specific circumstances. Establishes rate calculation requirements for reimbursement of nonparticipating providers.

 

HLT, CPC, FIN

HB 1881

Status

RELATING TO MEDICAL SERVICE BILLING.

Establishes billing requirements for unanticipated medical billing and unanticipated coverage gaps of patients for out-of-network emergency services received from non-participating providers. Specifies the circumstances in which health care providers and facilities can bill health carriers and enrollees for health intervention services that are medical necessities. Effective 1/1/2021.

 

HLT, CPC, FIN

HB 2456

Status

RELATING TO ELECTRONIC SMOKING PRODUCTS.

Establishes the offense of unlawful shipment of e-liquid products. Includes e-liquid and electronic smoking devices containing e-liquid within the definition of "tobacco products", as used in the cigarette tax and tobacco tax law. Allocates a portion of funds collected from excise taxes on tobacco products to health education and prevention programs about the risks and dangers of the use of electronic smoking devices for youth. Repeals certain provisions of the Hawaii Revised Statutes relating to electronic smoking devices.

 

HLT, CPC/JUD, FIN

HB 2347

Proposed HD1

Status

RELATING TO FLAVORED TOBACCO PRODUCTS.

Proposed HD1: Ban the sale of flavored tobacco products. Effective January 1, 2021.

 

Copies of the proposed HD1 are available in room 402 and on the Legislature's Web site: http://www.capitol.hawaii.gov.

 

HLT, CPC/JUD, FIN

HB 2348

Proposed HD1

Status

RELATING TO THE SALE OF TOBACCO PRODUCTS.

Proposed HD1: Establishes a schedule of penalties for employees and holders of retail tobacco permits or person registered to sell electronic cigarettes smoking devices who illegally sell tobacco products and electronic smoking device to persons under 21.

 

Copies of the proposed HD1 are available in room 402 and on the Legislature's Web site: http://www.capitol.hawaii.gov.

 

HLT, CPC/JUD, FIN

HB 2507

Status

RELATING TO HEALTH.

Prohibits the sale or furnishing of tobacco and tobacco products to persons under twenty-five years of age. Increases minimum age from twenty-one years of age to twenty-five years of age for purchase and possession of tobacco and tobacco products, including electronic smoking devices and increases fines.

 

HLT, JUD, FIN

HB 2540

Status

RELATING TO CIGARETTES.

Bans the sale of cigarettes and electronic cigarettes progressively by raising the minimum age of persons to whom cigarettes and electronic cigarettes may be legally sold to 30 years of age in 2021, 40 years of age in 2022, 50 years of age in 2023, 60 years of age in 2024, and then 100 years of age in 2025. Effective January 1, 2021.

 

HLT, CPC/JUD, FIN

HB 2046

Status

RELATING TO HEALTH.

Designates the month of September as Fetal Alcohol Spectrum Disorder Awareness Month to promote public awareness of the risks of alcohol consumption during pregnancy.

 

HLT, LMG, JUD

HB 2047

Status

RELATING TO HEALTH.

Establishes a task force within the Department of Health to identify therapies and home- and community-based care services that may benefit persons having fetal alcohol spectrum disorders, including therapies and treatments that may benefit them as adults. Requires the task force to recommend any necessary policy changes, rule changes, or legislation to increase access to these therapies and services. Requires a report to the Legislature.

 

HLT, FIN

HB 2096

Proposed HD1

Status

RELATING TO HEALTH.

Proposed HD1: Regulates cannabidiol under the department of health to be consistent with the Hawaii Food, Drug, and Cosmetic Act. Allows licensees under the industrial hemp pilot program to market their products to the consumer market in a manner that is regulated and tested for safety, purity, and potency.

 

Copies of the proposed HD1 are available in room 402 and on the Legislature's Web site: http://www.capitol.hawaii.gov.

 

HLT, CPC/JUD, FIN

HB 2097

Status

RELATING TO MEDICAL CANNABIS.

Allows for a process to remediate any batch of cannabis that fails laboratory testing standards so long as any final product passes all such laboratory standards. Authorizes licensed retail dispensaries to sell edible cannabis products, under certain conditions, and circulate, sponsor, and promote educational and scientific information and events related to cannabis.

 

HLT, CPC/JUD, FIN

HB 1843

Status

RELATING TO MEDICAL CANNABIS PRODUCTS.

Authorizes the manufacture and distribution of cannabis seeds and cannabis clones by medical cannabis dispensary licensees.

 

HLT, JUD, FIN

HB 2633

Status

RELATING TO CANNABIS FOR MEDICAL USE.

Authorizes dispensaries to distribute cannabis propagules and cuttings to individuals authorized to cultivate cannabis plants for medical use, subject to quantity limits and quality requirements.

 

HLT, JUD, FIN

 

 

 

 

DECISION MAKING TO FOLLOW

 

Persons wishing to offer comments should submit testimony at least 24 hours prior to the hearing. Testimony should indicate:

    Testifier's name with position/title and organization;

    The Committee(s) to which the comments are directed;

    The date and time of the hearing; and

    Measure number.

 

While every effort will be made to incorporate all testimony received, materials received on the day of the hearing or improperly identified or directed, may be distributed to the Committee after the hearing.

 

Submit testimony in ONE of the following ways:

PAPER: 10 copies (including an original) to Room 403 in the State Capitol;

FAX: For testimony less than 5 pages in length, transmit to 808-586-6311 (Oahu) or 1-800-535-3859 (for Neighbor Islander without a computer to submit testimony through e-mail or the Web); or

WEB: For testimony less than 20MB in size, transmit from http://www.capitol.hawaii.gov/submittestimony.aspx.

 

Testimony submitted will be placed on the legislative website. This public posting of testimony on the website should be considered when including personal information in your testimony.

 

If you require special assistance or auxiliary aids and/or services to participate in the House public hearing process (i.e., sign or foreign language interpreter or wheelchair accessibility), please contact the Committee Clerk at 586-6050 or email your request for an interpreter to HouseInterpreter@Capitol.hawaii.gov at least 24 hours prior to the hearing for arrangements. Prompt requests submitted help to ensure the availability of qualified individuals and appropriate accommodations.

 

 

 

 

 

________________________________________

Rep. John M. Mizuno

Chair